Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 577

1.

Comment on: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Lechat P, Ropers J, Barré J, Mouly S.

Clin Pharmacokinet. 2019 Oct;58(10):1351-1352. doi: 10.1007/s40262-019-00814-9. No abstract available.

PMID:
31452152
2.

Leishmania Genome Dynamics during Environmental Adaptation Reveal Strain-Specific Differences in Gene Copy Number Variation, Karyotype Instability, and Telomeric Amplification.

Bussotti G, Gouzelou E, Côrtes Boité M, Kherachi I, Harrat Z, Eddaikra N, Mottram JC, Antoniou M, Christodoulou V, Bali A, Guerfali FZ, Laouini D, Mukhtar M, Dumetz F, Dujardin JC, Smirlis D, Lechat P, Pescher P, El Hamouchi A, Lemrani M, Chicharro C, Llanes-Acevedo IP, Botana L, Cruz I, Moreno J, Jeddi F, Aoun K, Bouratbine A, Cupolillo E, Späth GF.

MBio. 2018 Nov 6;9(6). pii: e01399-18. doi: 10.1128/mBio.01399-18.

3.

Characterization of LE3 and LE4, the only lytic phages known to infect the spirochete Leptospira.

Schiettekatte O, Vincent AT, Malosse C, Lechat P, Chamot-Rooke J, Veyrier FJ, Picardeau M, Bourhy P.

Sci Rep. 2018 Aug 6;8(1):11781. doi: 10.1038/s41598-018-29983-6.

4.

Requests for post-registration studies (PRS), patients follow-up in actual practice: Changes in the role of databases.

Berdaï D, Thomas-Delecourt F, Szwarcensztein K, d'Andon A, Collignon C, Comet D, Déal C, Dervaux B, Gaudin AF, Lamarque-Garnier V, Lechat P, Marque S, Maugendre P, Méchin H, Moore N, Nachbaur G, Robain M, Roussel C, Tanti A, Thiessard F.

Therapie. 2018 Feb;73(1):13-24. doi: 10.1016/j.therap.2017.12.008. Epub 2017 Dec 30.

PMID:
29530314
5.

Demandes d’études post-inscription (EPI), suivi des patients en vie réelle : évolution de la place des bases de données.

Berdaï D, Thomas-Delecourt F, Szwarcensztein K; table ronde « recherche clinique et méthodologie » des Ateliers de Giens XXXIII, d'Andon A, Collignon C, Comet D, Déal C, Dervaux B, Gaudin AF, Lamarque-Garnier V, Lechat P, Marque S, Maugendre P, Méchin H, Moore N, Nachbaur G, Robain M, Roussel C, Tanti A, Thiessard F.

Therapie. 2018 Feb;73(1):1-12. doi: 10.1016/j.therap.2017.12.001. Epub 2017 Dec 12. French. No abstract available.

PMID:
29499906
6.

LipL21 lipoprotein binding to peptidoglycan enables Leptospira interrogans to escape NOD1 and NOD2 recognition.

Ratet G, Santecchia I, Fanton d'Andon M, Vernel-Pauillac F, Wheeler R, Lenormand P, Fischer F, Lechat P, Haake DA, Picardeau M, Boneca IG, Werts C.

PLoS Pathog. 2017 Dec 6;13(12):e1006725. doi: 10.1371/journal.ppat.1006725. eCollection 2017 Dec.

7.

[DocaMED smartphone app/Internet website on medicines and their therapeutic indications].

Lechat P, Ravoire S.

Therapie. 2017 Sep;72(4):503-504. doi: 10.1016/j.therap.2017.02.001. Epub 2017 Feb 20. French. No abstract available.

PMID:
28318611
8.

Listeriomics: an Interactive Web Platform for Systems Biology of Listeria.

Bécavin C, Koutero M, Tchitchek N, Cerutti F, Lechat P, Maillet N, Hoede C, Chiapello H, Gaspin C, Cossart P.

mSystems. 2017 Mar 14;2(2). pii: e00186-16. doi: 10.1128/mSystems.00186-16. eCollection 2017 Mar-Apr.

9.

Hospital-based health technology assessment in France: A focus on medical devices.

Martelli N, Puc C, Szwarcensztein K; participants of Giens XXXII, Round Table No. 4, Beuscart R, Coulonjou H, Degrassat-Théas A, Dutot C, Epis de Fleurian AA, Favrel-Feuillade F, Hounliasso I, Lechat P, Luigi E, Mairot L, Nguyen T, Piazza L, Roussel C, Vienney C.

Therapie. 2017 Feb;72(1):115-123. doi: 10.1016/j.therap.2017.01.002. Epub 2017 Jan 12.

PMID:
28189333
10.

Rôle et place de l’évaluation des technologies de santé à l’hôpital : schéma cible appliqué aux dispositifs médicaux.

Martelli N, Puc C, Szwarcensztein K; les participants à la table ronde n(o) 4 de Giens XXXII, Beuscart R, Coulonjou H, Degrassat-Théas A, Dutot C, Epis de Fleurian AA, Favrel-Feuillade F, Hounliasso I, Lechat P, Luigi E, Mairot L, Nguyen T, Piazza L, Roussel C, Vienney C.

Therapie. 2017 Feb;72(1):105-113. doi: 10.1016/j.therap.2016.11.056. Epub 2016 Dec 9. French. No abstract available.

PMID:
28043648
11.

Multiple major disease-associated clones of Legionella pneumophila have emerged recently and independently.

David S, Rusniok C, Mentasti M, Gomez-Valero L, Harris SR, Lechat P, Lees J, Ginevra C, Glaser P, Ma L, Bouchier C, Underwood A, Jarraud S, Harrison TG, Parkhill J, Buchrieser C.

Genome Res. 2016 Nov;26(11):1555-1564. Epub 2016 Sep 23.

12.

[Introduction of Health technology assessment at hospital].

Boudard A, Cordonnier AL, Martelli N, Lechat P, Sinègre M, Pineau J.

Ann Pharm Fr. 2016 Nov;74(6):473-481. doi: 10.1016/j.pharma.2016.03.001. Epub 2016 Apr 29. French.

PMID:
27139164
13.

Amoxicillin-clavulanic acid prescriptions at the Greater Paris University Hospitals (AP-HP).

Fusier I, Parent de Curzon O, Touratier S, Escaut L, Lafaurie M, Fournier S, Sinègre M, Lechat P, Vittecoq D; Anti-Infective Drug Committee (COMAI) of the public hospital system of the city of Paris (AP–HP).

Med Mal Infect. 2017 Feb;47(1):42-49. doi: 10.1016/j.medmal.2016.09.003. Epub 2016 Oct 17.

PMID:
27765474
14.

Intron retention-dependent gene regulation in Cryptococcus neoformans.

Gonzalez-Hilarion S, Paulet D, Lee KT, Hon CC, Lechat P, Mogensen E, Moyrand F, Proux C, Barboux R, Bussotti G, Hwang J, Coppée JY, Bahn YS, Janbon G.

Sci Rep. 2016 Aug 31;6:32252. doi: 10.1038/srep32252.

15.

Species- and Strain-Specific Adaptation of the HSP70 Super Family in Pathogenic Trypanosomatids.

Drini S, Criscuolo A, Lechat P, Imamura H, Skalický T, Rachidi N, Lukeš J, Dujardin JC, Späth GF.

Genome Biol Evol. 2016 Jul 2;8(6):1980-95. doi: 10.1093/gbe/evw140.

16.

Public T cell receptors confer high-avidity CD4 responses to HIV controllers.

Benati D, Galperin M, Lambotte O, Gras S, Lim A, Mukhopadhyay M, Nouël A, Campbell KA, Lemercier B, Claireaux M, Hendou S, Lechat P, de Truchis P, Boufassa F, Rossjohn J, Delfraissy JF, Arenzana-Seisdedos F, Chakrabarti LA.

J Clin Invest. 2016 Jun 1;126(6):2093-108. doi: 10.1172/JCI83792. Epub 2016 Apr 25.

17.

[Pharmacological Basis for Therapeutics. Pharmacological Analysis of Summary of Product Characteristics (SPC) for Physicians].

Lechat P.

Therapie. 2015 Sep-Oct;70(5):403-14. doi: 10.2515/therapie/2015025. Epub 2015 Jun 24. Review. French.

PMID:
26109291
18.

Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondes.

Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D; participants of round table N°3 of Giens XXX:, Bergmann JF, Casadevall N, Delval C, De Sahb Berkovitch R, Fagon JY, Gersberg M, Lassale C, Lechat P, Le Jeunne C, Montastruc JL, Prugnaud JL, Ratignier-Carbonneil C, Rey-Coquais C; 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé.

Therapie. 2015 Jan-Feb;70(1):37-55. doi: 10.2515/therapie/2015003. Epub 2015 Feb 16. Review. English, French.

PMID:
25679193
19.

Corrigendum: Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.

Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I, Spinali S, Perkins T, Lechat P, Dmytruk N, Sauvage E, Ma L, Romi B, Tichit M, Lopez-Sanchez MJ, Descorps-Declere S, Souche E, Buchrieser C, Trieu-Cuot P, Moszer I, Clermont D, Maione D, Bouchier C, McMillan DJ, Parkhill J, Telford JL, Dougan G, Walker MJ, Holden MT, Poyart C, Glaser P.

Nat Commun. 2015 Jan 28;6:6108. doi: 10.1038/ncomms7108. No abstract available.

20.

Biosimilars: from Technical to Pharmacoeconomic Considerations.

Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D; participants of round table N°3 of Giens XXX:, Bergmann JF, Casadevall N, Delval C, De Sahb Berkovitch R, Fagon JY, Gersberg M, Lassale C, Lechat P, Le Jeunne C, Montastruc JL, Prugnaud JL, Ratignier-Carbonneil C, Rey-Coquais C.

Therapie. 2015 Jan-Feb;70(1):47-55. doi: 10.2515/therapie/2015003.

PMID:
27393396
21.

Biosimilaires : de la technique au médicoéconomique.

Girault D, Trouvin JH, Blachier-Poisson C, Gary F, Laloye D; et les participants à la table ronde N°3 de Giens XXX :, Bergmann JF, Casadevall N, Delval C, De Sahb Berkovitch R, Fagon JY, Gersberg M, Lassale C, Lechat P, Le Jeunne C, Montastruc JL, Prugnaud JL, Ratignier-Carbonneil C, Rey-Coquais C.

Therapie. 2015 Jan-Feb;70(1):37-46. doi: 10.2515/therapie/2014233. French. No abstract available.

PMID:
27393395
22.

Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up.

Schoindre Y, Jallouli M, Tanguy ML, Ghillani P, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Hulot JS, Lechat P, Musset L, Piette JC, Amoura Z, Souberbielle JC, Costedoat-Chalumeau N; Group PLUS.

Lupus Sci Med. 2014 Jun 7;1(1):e000027. doi: 10.1136/lupus-2014-000027. eCollection 2014.

23.

Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situations.

Molimard M, Bernaud C, Lechat P; participants of round table n6 of Giens XXIX: Bejan-Angoulvant Theodora 4 Benattia Cherif 5 Benkritly Amel 6, Bejan-Angoulvant T, Benattia C, Benkritly A, Braunstein D, Cabut S, David N, Fourrier-Réglat A, Gallet B, Gersberg M, Goni S, Jolliet P, Lamarque-Garnier V, Le Jeunne C, Leurs I, Liard F, Malbezin M, Micallef J, Nguon M.

Therapie. 2014 Jul-Aug;69(4):355-66. doi: 10.2515/therapie/2014045. Epub 2014 Aug 8. English, French.

PMID:
25099666
24.

Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline.

Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I, Spinali S, Perkins T, Lechat P, Dmytruk N, Sauvage E, Ma L, Romi B, Tichit M, Lopez-Sanchez MJ, Descorps-Declere S, Souche E, Buchrieser C, Trieu-Cuot P, Moszer I, Clermont D, Maione D, Bouchier C, McMillan DJ, Parkhill J, Telford JL, Dougan G, Walker MJ; DEVANI Consortium, Holden MTG, Poyart C, Glaser P.

Nat Commun. 2014 Aug 4;5:4544. doi: 10.1038/ncomms5544. Erratum in: Nat Commun. 2015;6:6108.

25.

Information et communication sur les risques liés au médicament et son bon usage auprès des professionnels de santé et du public : principe de précaution, gestion du risque, communication pendant et en dehors des situations de crise.

Molimard M, Bernaud C, Lechat P; et les participants à la table ronde N°6 de Giens XXIX :, Bejan-Angoulvant T, Benattia C, Benkritly A, Braunstein D, Cabut S, David N, Fourrier-Réglat A, Gallet B, Gersberg M, Goni S, Jolliet P, Lamarque-Garnier V, Le Jeunne C, Leurs I, Liard F, Malbezin M, Micallef J, Nguon M.

Therapie. 2014 Jul-Aug;69(4):355-60. doi: 10.2515/therapie/2014044. French. No abstract available.

PMID:
27393228
26.

Comparison of widely used Listeria monocytogenes strains EGD, 10403S, and EGD-e highlights genomic variations underlying differences in pathogenicity.

Bécavin C, Bouchier C, Lechat P, Archambaud C, Creno S, Gouin E, Wu Z, Kühbacher A, Brisse S, Pucciarelli MG, García-del Portillo F, Hain T, Portnoy DA, Chakraborty T, Lecuit M, Pizarro-Cerdá J, Moszer I, Bierne H, Cossart P.

MBio. 2014 Mar 25;5(2):e00969-14. doi: 10.1128/mBio.00969-14.

27.

The intestinal microbiota interferes with the microRNA response upon oral Listeria infection.

Archambaud C, Sismeiro O, Toedling J, Soubigou G, Bécavin C, Lechat P, Lebreton A, Ciaudo C, Cossart P.

MBio. 2013 Dec 10;4(6):e00707-13. doi: 10.1128/mBio.00707-13.

28.

SynTView - an interactive multi-view genome browser for next-generation comparative microorganism genomics.

Lechat P, Souche E, Moszer I.

BMC Bioinformatics. 2013 Sep 22;14:277. doi: 10.1186/1471-2105-14-277.

29.

How can the quality of medical data in pharmacovigilance, pharmacoepidemiology and clinical studies be guaranteed?

Alla F, Rosilio M, Funck-Brentano C; Participants of round table N° 2 of Giens Workshops XXVIII (th), Barthélémy P, Brisset S, Cellier D, Chassany O, Demarez JP, Diebolt V, Francillon A, Gambotti L, Hannachi H, Lechat P, Lemaire F, Lièvre M, Misse C, Nguon M, Pariente A, Rosenheim M, Weisslinger-Darmon N.

Therapie. 2013 Jul-Aug;68(4):209-23. doi: 10.2515/therapie/2013040. Epub 2013 Aug 28. English, French.

30.

Comment garantir des données médicales de qualité dans les études cliniques, pharmaco-épidémiologiques et en pharmacovigilance ?

Alla F, Rosilio M, Funck-Brentano C; les participants à la table ronde N° 2 de Giens XXVIII :, Barthélémy P, Brisset S, Cellier D, Chassany O, Demarez JP, Diebolt V, Francillon A, Gambotti L, Hannachi H, Lechat P, Lemaire F, Lièvre M, Misse C, Nguon M, Pariente A, Rosenheim M, Weisslinger-Darmon N.

Therapie. 2013 Jul-Aug;68(4):209-16. doi: 10.2515/therapie/2013035. French. No abstract available.

PMID:
27392724
31.

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).

Costedoat-Chalumeau N, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin du LT, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Tanguy ML, Hulot JS, Lechat P, Musset L, Amoura Z, Piette JC; Group PLUS.

Ann Rheum Dis. 2013 Nov;72(11):1786-92. doi: 10.1136/annrheumdis-2012-202322. Epub 2012 Nov 10.

PMID:
23144449
32.

Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety.

Paintaud G, Diviné M, Lechat P; participants of Round Table N°5 of Giens XXVII.

Therapie. 2012 Jul-Aug;67(4):329-37. doi: 10.2515/therapie/2012046. Epub 2012 Nov 1.

33.

Anticorps monoclonaux à usage thérapeutique : spécificités du développement clinique, évaluation par les agences, suivi de la tolérance à long terme.

Paintaud G, Diviné M, Lechat P; les participants à la table ronde N° 5 de Giens XXVII.

Therapie. 2012 Jul-Aug;67(4):319-27. doi: 10.2515/therapie/2012043. Epub 2012 Nov 1. French. No abstract available.

PMID:
23110832
Free Article
34.

Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy.

Simon N, Marsot A, Villard E, Choquet S, Khe HX, Zahr N, Lechat P, Leblond V, Hulot JS.

Pharmacogenomics J. 2013 Dec;13(6):507-13. doi: 10.1038/tpj.2012.37. Epub 2012 Oct 16.

PMID:
23069858
35.

Impact of lactobacilli on orally acquired listeriosis.

Archambaud C, Nahori MA, Soubigou G, Bécavin C, Laval L, Lechat P, Smokvina T, Langella P, Lecuit M, Cossart P.

Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16684-9. doi: 10.1073/pnas.1212809109. Epub 2012 Sep 24.

36.

Anticorps monoclonaux à usage thérapeutique : spécificités du développement clinique, évaluation par les agences, suivi de la tolérance à long terme.

Paintaud G, Diviné M, Lechat P; participants à la table ronde N°5 de Giens XXVII.

Therapie. 2012 Jul-Aug;67(4):319-27. doi: 10.2515/therapie/2012043. French. No abstract available.

PMID:
27393609
37.

Assessment of the health risks related to the presence of drug residues in water for human consumption: application to carbamazepine.

Houeto P, Carton A, Guerbet M, Mauclaire AC, Gatignol C, Lechat P, Masset D.

Regul Toxicol Pharmacol. 2012 Feb;62(1):41-8. doi: 10.1016/j.yrtph.2011.11.012. Epub 2011 Dec 8.

PMID:
22178769
38.

How to improve the clinical development paradigm and its division into phases I, II and III.

Bamberger M, Moore N, Lechat P; participants of Round Table N° 3 of Giens XXVI.

Therapie. 2011 Jul-Aug;66(4):331-4, 327-30. Epub 2011 Aug 19. English, French.

39.

Comment faire évoluer le paradigme du développement clinique et son découpage en phases I, II, III.

Bamberger M, Moore N, Lechat P; participants à la Table Ronde N◦ 3 de Giens XXVI.

Therapie. 2011 Jul-Aug;66(4):327-30. doi: 10.2515/therapie/2011043. French. No abstract available.

PMID:
27392459
40.

Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II).

Gallanagh S, Castagno D, Wilson B, Erdmann E, Zannad F, Remme WJ, Lopez-Sendon JL, Lechat P, Follath F, Höglund C, Mareev V, Sadowski Z, Seabra-Gomes RJ, Dargie HJ, McMurray JJ.

Cardiovasc Drugs Ther. 2011 Feb;25(1):77-85. doi: 10.1007/s10557-011-6284-x.

41.

Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European level.

Berdaï D, Hotton JM, Lechat P; participates of Round Table n° 1 Giens XXV.

Therapie. 2010 Jul-Aug;65(4):329-34. doi: 10.2515/therapie/2010035. Epub 2010 Sep 21.

PMID:
20854755
42.

Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period.

Hammoud HA, Aymard G, Lechat P, Boccheciampe N, Riou B, Aubrun F.

Fundam Clin Pharmacol. 2011 Aug;25(4):518-27. doi: 10.1111/j.1472-8206.2010.00867.x. Epub 2010 Sep 6.

PMID:
20825489
43.

Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality.

Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ, Dargie HJ; CIBIS-2 Investigators and Committees.

Eur J Heart Fail. 2010 Sep;12(9):974-82. doi: 10.1093/eurjhf/hfq118. Epub 2010 Aug 4.

44.

Les comparateurs (médicamenteux et non médicamenteux) pour l'autorisation de mise sur le marché, pour la santé publique, pour les payeurs et au niveau européen.

Berdaï D, Hotton JM, Lechat P; les participants à la Table Ronde n°1 de Giens XXV.

Therapie. 2010 Jul-Aug;65(4):323-8. doi: 10.2515/therapie/2010032. French. No abstract available.

PMID:
27393111
45.

Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.

Krum H, van Veldhuisen DJ, Funck-Brentano C, Vanoli E, Silke B, Erdmann E, Follath F, Ponikowski P, Goulder M, Meyer W, Lechat P, Willenheimer R; behalf of the CIBIS III Investigators.

Cardiovasc Ther. 2011 Apr;29(2):89-98. doi: 10.1111/j.1755-5922.2010.00185.x.

PMID:
20528880
46.

Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial.

Castagno D, Jhund PS, McMurray JJ, Lewsey JD, Erdmann E, Zannad F, Remme WJ, Lopez-Sendon JL, Lechat P, Follath F, Höglund C, Mareev V, Sadowski Z, Seabra-Gomes RJ, Dargie HJ.

Eur J Heart Fail. 2010 Jun;12(6):607-16. doi: 10.1093/eurjhf/hfq038. Epub 2010 Mar 30.

47.

Quantification of coproporphyrin isomers I and III in urine by HPLC and determination of their ratio for investigations of multidrug resistance protein 2 (MRP2) function in humans.

Respaud R, Benz-de Bretagne I, Blasco H, Hulot JS, Lechat P, Le Guellec C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 15;877(30):3893-8. doi: 10.1016/j.jchromb.2009.09.047. Epub 2009 Oct 8.

PMID:
19836315
48.

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.

Jondeau G, Neuder Y, Eicher JC, Jourdain P, Fauveau E, Galinier M, Jegou A, Bauer F, Trochu JN, Bouzamondo A, Tanguy ML, Lechat P; B-CONVINCED Investigators.

Eur Heart J. 2009 Sep;30(18):2186-92. doi: 10.1093/eurheartj/ehp323. Epub 2009 Aug 30.

PMID:
19717851
49.

Intravenous morphine titration in immediate postoperative pain management: population kinetic-pharmacodynamic and logistic regression analysis.

Abou Hammoud H, Simon N, Urien S, Riou B, Lechat P, Aubrun F.

Pain. 2009 Jul;144(1-2):139-46. doi: 10.1016/j.pain.2009.03.029. Epub 2009 May 10.

PMID:
19435651
50.

RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the rat.

Aubart FC, Sassi Y, Coulombe A, Mougenot N, Vrignaud C, Leprince P, Lechat P, Lompré AM, Hulot JS.

Mol Ther. 2009 Mar;17(3):455-62. doi: 10.1038/mt.2008.291. Epub 2008 Dec 23.

Supplemental Content

Loading ...
Support Center